Enhanced radioiodine uptake in a patient with poorly differentiated papillary thyroid cancer after treatment with rosiglitazone

被引：17
|
作者：
Elias, Alan N.
Lizotte, Paul
机构：
[1] Univ Calif Irvine, Med Ctr, Dept Med, Orange, CA 92868 USA
[2] Univ Calif Irvine, Med Ctr, Dept Radiol, Orange, CA 92868 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2006年 / 31卷 / 09期
关键词：
PPAR; rosiglitazone; thyroid cancer; differentiation therapy;
D O I：
10.1097/01.rlu.0000233148.45744.44
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The effect of pretreatment with the peroxisome proliferator-activated receptor (PPAR) agonist, rosiglitazone, on radioiodine uptake and serum thyroglobulin levels in a patient with radioiodine-resistant papillary thyroid cancer is described. Treatment with rosiglitazone resulted in enhanced radioiodine uptake in areas of presumed metastatic disease in the neck that were previously only faintly seen, and serum thyroglobulin fell from a pretreatment level of 41 ng/mL to less than 2 ng/mL.
引用
收藏
页码：517 / 519
页数：3
相关论文
共 50 条
  • [1] False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
    Daniele Barbaro
    Alfredo Campennì
    Raffaella Forleo
    Paola Lapi
    [J]. Endocrine, 2023, 81 : 30 - 35
  • [2] False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
    Barbaro, Daniele
    Campenni, Alfredo
    Forleo, Raffaella
    Lapi, Paola
    [J]. ENDOCRINE, 2023, 81 (01) : 30 - 35
  • [3] Unusual Uptake of Radioiodine in a Subcutaneous Lipoma in a Patient With Differentiated Thyroid Cancer
    Shen, Guohua
    Jing, Xiaolin
    Zhang, Yuan
    Kuang, Anren
    Huang, Rui
    [J]. CLINICAL NUCLEAR MEDICINE, 2017, 42 (01) : E75 - E76
  • [4] Redifferentiation Therapy with Rosiglitazone in a case of Differentiated Thyroid Cancer with Pulmonary Metastases and Absence of Radioiodine Uptake
    Elola, M.
    Yoldi, A.
    Emparanza, J. I.
    Matteucci, T.
    Bilbao, I.
    Goena, M.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2011, 30 (04): : 241 - 243
  • [5] Radioiodine treatment for differentiated thyroid cancer
    Vini, L
    Harmer, C
    [J]. CLINICAL ONCOLOGY, 2000, 12 (06) : 365 - 372
  • [6] Diagnosis of poorly differentiated thyroid cancer with radioiodine scanning after thyrotropin alfa stimulation
    Juweid, Malik
    O'Dorisio, Thomas
    Milhem, Mohammed
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (12): : 1295 - 1297
  • [7] False-Positive Uptake of Radioiodine in Renal Hamartoma in a Patient With Differentiated Thyroid Cancer
    Shen, Guohua
    Qi, Zhongzhi
    Huang, Rui
    Liu, Bin
    Kuang, Anren
    [J]. CLINICAL NUCLEAR MEDICINE, 2017, 42 (09) : 709 - +
  • [8] Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option
    Jérôme Clerc
    Frederik A. Verburg
    Anca M. Avram
    Luca Giovanella
    Elif Hindié
    David Taïeb
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 918 - 925
  • [9] Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option
    Clerc, Jerome
    Verburg, Frederik A.
    Avram, Anca M.
    Giovanella, Luca
    Hindie, Elif
    Taieb, David
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (06) : 918 - 925
  • [10] Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
    Esquerré-Lamare C.
    Isus F.
    Moinard N.
    Bujan L.
    [J]. Basic and Clinical Andrology, 2015, 25 (1)
12345